Cargando…
Early immunomodulators with CAR T-cell immunotherapy in the COVID-19 era
Autor principal: | Abid, Muhammad Bilal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8801769/ https://www.ncbi.nlm.nih.gov/pubmed/34973215 http://dx.doi.org/10.1016/S1470-2045(21)00695-1 |
Ejemplares similares
-
Potential solutions for manufacture of CAR T cells in cancer immunotherapy
por: Blache, Ulrich, et al.
Publicado: (2022) -
Diagnosis of EVALI in the COVID-19 era
por: Kazachkov, Mikhail, et al.
Publicado: (2020) -
Prioritisation of COVID-19 boosters in the omicron era
por: Irving, Stephanie A, et al.
Publicado: (2022) -
Offline: Science and politics in the era of COVID-19
por: Horton, Richard
Publicado: (2020) -
Participant stress in the COVID-19 era and beyond
por: Goldfarb, Elizabeth V.
Publicado: (2020)